Camilla Chello
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Reflectance Confocal Microscopy Integrated With Dermoscopy in a Real-World Tertiary Referral Cohort: Diagnostic Agreement, Management Outcomes, and Number Needed to Excise in 1057 Lesions.
Journal: International journal of dermatology
Published: May 31, 2026
Reflectance Confocal Microscopy Versus Line-Field Confocal Optical Coherence Tomography in Facial and Scalp Lesions Suspicious for Basal Cell Carcinoma: A Histopathology-Referenced Multi-Reader Study.
Journal: International journal of dermatology
Published: May 21, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Journal: Dermatology and therapy
Published: March 11, 2026
Tufted hair folliculitis as an unusual cutaneous manifestation of systemic Langerhans cell histiocytosis.
Journal: Italian journal of dermatology and venereology
Published: February 24, 2026
In Vivo Non-Invasive High-Resolution Imaging for the Evaluation of the Periocular Skin Area: A Comprehensive Review of the Literature.
Journal: Journal of clinical medicine
Published: December 28, 2025
Analysis with LC-OCT imaging in split face with CO2 laser and 1540 nm. A case report.
Journal: Oxford medical case reports
Published: November 12, 2025
Optimizing military teledermatology: A controlled interventional study on the impact of a standardized store-and-forward protocol.
Journal: Journal of the American Academy of Dermatology
Published: October 26, 2025
Optimizing Military Teledermatology: A Controlled Interventional Study on the Impact of a Standardized Store-and-Forward Protocol.
Journal: Journal of the American Academy of Dermatology
Published: October 26, 2025
New Insights into Pathogenesis and Management of Keratoacanthoma: A Narrative Review.
Journal: International journal of molecular sciences
Published: August 20, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: August 12, 2025
Last Updated: 09/26/2026